Search Results 281-290 of 17265 for egfr

1. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

   The patient has severe renal impairment (eGFR < 30). Additional Exclusion Criteria for PK Sub-Study. The patient meets any of Primary Exclusion Criteria #1 ...

2. A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

   ... (EGFR) inhibitor (eg, cetuximab, panitumumab). - Previous treatment with an immune checkpoint inhibitor (eg, anti-programmed cell death [PD-1], anti-PD-L1 or ...

3. Breast MR - Mayo Clinic

   eGFR ≤ 30 (4,5). History of prior moderate or severe contrast reaction including unresponsiveness, severe respiratory distress, convulsions, arrhythmia ...

4. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR) - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) < 30 mL/min/m^2 (as defined by the Modification of Diet in Renal Disease [MDRD] equation);; Serum alanine ...

5. TruGraf® Long-term Clinical Outcomes Study

   ... eGFR and proteinuria (P<0.001). Subclinical ABMR was associated with more rapid progression to transplant glomerulopathy. Of patients with subclinical TCMR ...

6. Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program

   ... EGFR or ALK genomic tumor aberrations;; First-line treatment of adult patients with intermediate or poor risk advanced renal cell carcinoma (RCC); ...

7. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

   Contraindications to contrast-enhanced PCD-CT (eGFR < 30, history of previous contrast allergic reaction, history of premedication prior to iodinated contrast).

8. Iga Nephropathy Clinical Trials

   ... eGFR ≥ 20 mL/min/1.73m2 and per Investigator's clinical judgement may benefit from receiving open-label iptacopan, despite optimal supportive treatment.

9. A Study to Evaluate Effectiveness of Preventing Urinary Stones With Hydration - Mayo Clinic

   Chronic kidney disease (eGFR <30 ml/min/1.7 m2 over a 3‐month period):. For adults (age ≥18), we will use the CKD‐Epi equation which requires the ...

10. A Study To Assess Imaging Tools For Patients Who Have Prostate Removal Surgery - Mayo Clinic

    eGFR should be above 30 within 30 days the time of mpMRI. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...